Related Experiment Video
Updated: May 4, 2026
10:03
Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
Published on: November 11, 2016
7.9K
Induced pluripotent stem cell (iPSCs) and their application in immunotherapy
Cellular & Molecular Immunology
|December 17, 2013
Summary
Induced pluripotent stem cells (iPSCs) offer promising applications in immunology, disease modeling, and regenerative medicine. However, challenges like immunogenicity require further research for successful clinical translation.
Area of Science:
- Immunology
- Stem Cell Biology
- Regenerative Medicine
Background:
- Induced pluripotent stem cells (iPSCs) present a valuable alternative to embryonic stem cells (ESCs) due to their self-renewal capacity and lack of ethical concerns.
- iPSCs hold significant potential for applications within the immune system, including disease modeling, drug screening, and cell therapy.
Purpose of the Study:
- To review recent advancements in iPSC differentiation methods for immunological applications.
- To discuss the clinical implications of iPSCs in the context of the immune system.
- To address current challenges and controversies, particularly regarding iPSC immunogenicity.
Main Methods:
- Review of current literature on iPSC differentiation and immunological applications.
- Analysis of studies on reprogramming hematopoietic and mature immune cells into iPSCs.
- Discussion of clinical trials and preclinical research involving iPSCs for immune system applications.
Main Results:
- Successful reprogramming of various immune cells to iPSCs and vice versa has been demonstrated.
- iPSCs offer unique advantages for patient-specific disease modeling and potential cell sources for transfusion medicine.
- The immunogenicity of iPSCs and their derivatives remains a significant, debated limitation for clinical use.
Conclusions:
- iPSCs show great promise for advancing immunology, regenerative medicine, and personalized therapies.
- Further research is crucial to overcome challenges such as immunogenicity for safe and effective clinical translation.
- Continued investigation into differentiation protocols and immunomodulatory strategies is essential for harnessing the full potential of iPSCs in the immune system.
Related Concept Videos
01:22iPS Cell Differentiation
2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K
01:13Induced Pluripotent Stem Cells
22.9K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
22.9K
01:06Induced Pluripotent Stem Cells
4.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.8K
01:13Induced Pluripotent Stem Cells
3.4K
3.4K
01:21EPS and iPS Cells in Disease Research
3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K
01:29Somatic to iPS Cell Reprogramming
2.1K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.1K